AngioLab Inc
251280
Company Profile
Business description
AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.
Contact
65 Techno 3ro
Suite 159
Hanshin S Mecca
Yuseong-gu
Doejeon
CHNT: +86 428675785
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
16
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,770.20 | 79.30 | 0.91% |
| CAC 40 | 7,804.67 | 40.83 | 0.53% |
| DAX 40 | 24,276.48 | 184.86 | 0.77% |
| Dow JONES (US) | 42,427.74 | 91.90 | -0.22% |
| FTSE 100 | 8,801.29 | 14.27 | 0.16% |
| HKSE | 23,654.03 | 141.54 | 0.60% |
| NASDAQ | 19,460.49 | 61.53 | 0.32% |
| Nikkei 225 | 37,747.45 | 300.64 | 0.80% |
| NZX 50 Index | 12,549.30 | 54.59 | 0.44% |
| S&P 500 | 5,970.81 | 0.44 | 0.01% |
| S&P/ASX 200 | 8,541.80 | 75.10 | 0.89% |
| SSE Composite Index | 3,376.20 | 14.23 | 0.42% |